This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ajinomoto Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Unlocking the Future of Pancreatic Cancer Evaluation: The Innovations of Nobuyasu Fukutake
Introduction: Nobuyasu Fukutake, a prominent inventor based in Osaka, Japan, has made significant strides in the field of medical technology. With a focus on pancreatic cancer evaluation, Fukutake has developed a patented method that harnesses the power of amino acid concentration data to assess the state of this critical disease.
Latest Patents: Fukutake's sole patent, titled "Method for Evaluating Pancreatic Cancer," introduces a groundbreaking approach to diagnosing pancreatic cancer. This comprehensive method consists of two main steps: first, the acquisition of amino acid concentration data from blood samples collected from patients and, second, the evaluation of the pancreatic cancer state using a specially formulated mathematical equation. The patent emphasizes the concentrations of various amino acids, including Asn, His, Thr, Ala, and others, demonstrating the complexity and precision of this evaluation process.
Career Highlights: Fukutake is associated with Ajinomoto Co., Ltd., a leading company known for its innovations in food products and biotechnology. His work at Ajinomoto has positioned him at the forefront of research and development in the medical field, particularly in diagnostic technologies.
Collaborations: Throughout his career, Fukutake has collaborated with esteemed colleagues, including Nobukazu Ono and Atsuko Shinhara. These partnerships foster a dynamic environment for innovation and contribute significantly to advancing medical diagnostics.
Conclusion: Nobuyasu Fukutake's inventive contributions represent a significant leap forward in pancreatic cancer evaluation. With his unique patent and collaborative efforts at Ajinomoto Co., Ltd., he is paving the way for more accurate and effective diagnostic methods in the healthcare industry. Through his innovations, Fukutake is not only addressing a pressing medical need but is also inspiring future advancements in the field of medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile